However, in many cases, human cancer exhibits a TAP-negative phenotype, and thus it is still unclear whether B7.1 expression in these tumor cells can elicit the protective T-cell immunity or whether expression of both B7.1 and TAP1 genes is required to generate such immunity. The gene discussed is CD80; the disease is cancer.